Jose Gerard Monzon - Concepedia

Author

Jose Gerard Monzon

Also Known As

J G Monzon, J Monzon, J. G. Monzon, J. Monzon, J.G. Monzon, Jose David Umaña Monzón, Jose G Monzon, Jose G. Monzon, Jose Gerard Monzon, Jose Monzon

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

University of Calgary BC Cancer Agency Princess Margaret Cancer Centre Ottawa Hospital University of Toronto

About

Jose Gerard Monzon is an author at University of Calgary specializing in cancer research, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	613
2	Health Sciences	3	3	86
3	Business	1	1	14
4	Engineering	1	1	14
5	Public Health	1	1	18

Jose Gerard Monzon

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Mutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma Ling Liu, David Dilworth, Luzhang Gao, Nature Genetics Cdkn2a 5Tumor BiologyAberrant Initiation CodonPhotocarcinogenesisMelanoma	1999	278
<i>CDKN2A</i>Mutations in Multiple Primary Melanomas Jose Gerard Monzon, Ling Liu, Herbert Brill, New England Journal of Medicine	1998	268
A phase 2 study of tremelimumab in patients with advanced uveal melanoma Anthony M. Joshua, Jose Gerard Monzon, Catalin Mihalcioiu, Melanoma Research Durable Response RateImmunologyImmunoeditingDermatologyImmunotherapy	2015	102
Anti-PD1-Induced Immune-Related Adverse Events and Survival Outcomes in Advanced Melanoma Aleksi Suo, Yin Chan, Carissa Beaulieu, The Oncologist	2020	75
Predictors of Pathologic Complete Response After Neoadjuvant Treatment for Rectal Cancer: A Multicenter Study Dawn Elizabeth Armstrong, Soundouss Raissouni, Julie Price Hiller, Clinical Colorectal Cancer Surgical OncologyPathologic Complete ResponseGastrointestinal OncologyMedicineCancer Recurrence	2015	67
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation Shaan Dudani, Horia Marginean, Patricia A. Tang, BMC Cancer	2019	60
Association of Immune-Related Adverse Events, Hospitalization, and Therapy Resumption With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Immunotherapy Alexander Watson, Siddhartha Goutam, Igor Stukalin, JAMA Network Open	2022	58
Association Between <i>SLC16A5</i> Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer Britt I. Drögemöller, Jose Gerard Monzon, Amit P. Bhavsar, JAMA Oncology	2017	49
Outcomes of patients with solid tumour malignancies treated with first-line immuno-oncology agents who do not meet eligibility criteria for clinical trials Chun Loo Gan, Igor Stukalin, Daniel E. Meyers, European Journal of Cancer	2021	46
Validation of predictive models for germline mutations in DNA mismatch repair genes in colorectal cancer Jose Gerard Monzon, Carol Cremin, Linlea Armstrong, International Journal of Cancer Genome InstabilityOncologySomatic VariantMmr Gene MutationGenetic Disorder	2009	45

Page 1